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Introduction
Myocardial infarction (MI) is one of the major causes of heart failure. MI induces cardiomyocyte death, followed by infiltration of immune cells into post-infarct myocardium. The immune cells positively or negatively regulate myocardial inflammation and modulate adverse cardiac remodeling [1] [2] [3] . For instance, neutrophils infiltrate into infarcted myocardium immediately after coronary occlusion and aggravate tissue damage by producing reactive oxygen species (ROS) [4, 5] . In contrast, macrophages contribute to the clearance of dead cells after MI and promote angiogenesis, leading to wound healing [6] [7] [8] . Therefore, in order to understand the importance of immune cells in cardiac remodeling, it would be required to make clear the biological functions of immune cells based on cell-lineage in more detail.
The retinoic acid receptor-related orphan nuclear receptor γt (RORγt) was originally identified as an essential transcription factor for IL-17A producing T cell differentiation [9, 10] . Physiologically, IL-17A plays important roles in host protection against the microbial infection in the bowels [11] [12] [13] . IL-17A is also implicated in the pathogenesis of various inflammatory diseases such as atherosclerosis [14, 15] , psoriasis [16, 17] and autoimmune diseases [18, 19] . Interestingly, recent studies have proposed that the deficiency of IL-17A could ameliorate left ventricular remodeling after MI [20, 21] , suggesting that IL-17A is detrimental to the maintenance of cardiac homeostasis after MI; however, it is required to clarify the biological significance of RORγt-expressing cells that produce IL-17A, because IL-17A is a pleiotropic cytokine and locally functions in various tissues.
RORγt-expressing cells express various cytokines and cytokine receptors, including IL-17F and IL-23R, as well as IL-17A [22, 23] . In this study, we addressed the pathophysiological roles of RORγt-expressing cells in cardiac remodeling after MI, using mice with enhanced GFP (eGFP) gene heterozygously knocked-in at RORγt locus (RORγt +/-mice), because homozygous deletion of RORγt gene showed higher mortality by coronary ligation, compared with WT or RORγt +/-mice, in our preliminary study. In RORγt +/-mice, the myocardial expression of RORγt and IL-17A was reduced in the heart after MI, compared with wild-type (WT) mice. Importantly, post-infarct cardiac remodeling was exacerbated in RORγt +/-mice, accompanied by reduced capillary density, suggesting that RORγt-expressing cells ameliorate cardiac remodeling after MI. The present study is the first demonstration that RORγt-expressing cells exhibit cardioprotective properties after MI.
Materials and methods

Animal care
Animal care was performed according to the Osaka University animal care guidelines. The study was approved by the Institutional Animal Care and Use Committee of the Graduate School of Pharmaceutical Science, Osaka University (Permit Number; DOUYAKU 26-4). All animal experiments were in accordance with the Guide for the Care and Use of Laboratory Animals, Eighth Edition, updated by the US National Research Council Committee in 2011.
Male C57BL/6 mice (8-12 weeks old, 25-30g body weight) were purchased from Japan SLC, Inc, and maintained on a 12 h light/dark cycle with free access to food and water at Animal Care Facility of Graduate School of Pharmaceutical Sciences, Osaka University. At the endpoints of all experiments, the hearts were excised from isoflurane-anesthetized mice. All efforts were made to minimize suffering.
Induction of MI
Murine MI was induced by permanent ligation of the left anterior descending coronary artery as previously described [24] .
Splenectomy surgery
Mice were ventilated and anesthetized by isoflurane. After the left-side small laparotomy, splenic vessels were ligated with 7-0 silk sutures and the spleen was removed. The peritoneum and skin were closed with 5-0 silk sutures. MI operation was performed immediately after the splenic removal.
RORγt-enhanced green fluorescence protein (eGFP) transgenic mice
The genetically engineered mice with eGFP cDNA knocked-in at RORγt gene locus on a C57BL/6 background, designated as RORγt +/-mice, were purchased from Jackson Laboratories (stock number: 007572). Genomic DNA was prepared from RORγt WT, RORγt
, and RORγt -/-mice. The genotyping of RORγt and eGFP was performed by PCR using specific primers. The primers used for genotyping were as follows: RORγt and eGFP forward 5'-GC C ACC TGT GTG GAG CAG AGC TTA -3', RORγt reverse 5'-GGA TGC CCC CAT TCA CTT ACT TCT -3', eGFP reverse 5'-TCC TTG AAG AAG ATG GTG CG -3'. 
Quantitative RT-PCR
Total RNA sample was prepared using QIAzol reagent (QIAGEN). RT-PCR was performed according to the manufacturer's protocol, as described previously [25] . The expression of RORγt, VEGF, CXCL5, angiopoietin 2, IL-17A, IL-17F, IL-23R, IL-6, IL-1β, TNF-α, IFN-γ, IL-10, and TGF-β mRNA in the left ventricle (LV) from the ligation point to the apex was estimated by real-time PCR using the SYBR green system (Applied Biosystems). The expression of GAPDH was measured and used as an internal control. The primers used in this study are shown in Supplementary material online, S1 Table.
Histological analysis
Cardiac injury was histologically estimated as described previously [24, 26] . Briefly, hearts were harvested at day 7 after MI. The hearts were sliced from the position about 300 μm distal to the ligation point at 5-μm thickness, followed by staining with Masson's trichrome method. The area or circumference ratio of the injured region to LV was measured using Image J software (National Institutes of Health) by a researcher who was blinded to the experimental condition.
Immunohistochemical analysis was performed as described previously [24] . In brief, frozen sections were fixed with 4% paraformaldehyde (PFA) or acetone. RORγt-expressing cells infiltration was stained using Histofine Mousestain kit (Nichirei Bioscience) with mouse antiRORγt monoclonal antibody (Clone: Q31-378, BD Bioscience). Mouse non-immune IgG (Santa Cruz Biotechnology) was used as control. Nuclei were counterstained with hematoxylin. To estimate the number of RORγt-expressing cells, photomicrographs of border area and remote area were taken at random. Border area was defined as the region < 1 mm from the end of infarct area. RORγt-positive cells were counted in number by the researcher who was blinded to the assay condition.
To estimate the capillary density, capillary vessels were stained using a Vectastain ABC kit (Vector Laboratories) with rat anti-CD31 monoclonal antibody (Clone: MEC13.3, BD Bioscience). Sections were photographed at border area, and then CD31-positive cells were counted in number by the researcher who was blinded to the assay condition.
Flow cytometric analysis
Spleens were harvested, triturated, and passed through a 70 μm cell strainer in PBS containing 3% fetal bovine serum (FBS). Cells were treated Lysing buffer (BD Bioscience) to exclude erythrocytes. To block Fc receptors, cells were incubated with rat anti-CD16/32 monoclonal antibody (Clone: 93, BioLegend) on ice for 15 minutes. Cells were stained surface markers with PE-conjugated armenian hamster anti-γδTCR monoclonal antibody (Clone: GL3, BioLegend) and FITC-conjugated rat anti-CD4 monoclonal antibody (Clone: RM4-5, BD Bioscience) on ice for 40 minutes. Transcription Factor Staining Buffer Set (eBioscience) was used for intracellular staining according to the manufacturer's protocol. After fixation and permeabilization, cells were stained with APC-conjugated rat anti-RORγt antibody (Clone: B2D, eBioscience) on ice for 40 minutes. Isotype-control staining was performed using FITC-or APC-conjugated rat control IgG (Clone: RTK2758, BioLeged) and PE-conjugated rat control IgG (Clone: R35-95, BD Bioscience). Flow cytometric analysis was performed on FACS Aria II (BD Bioscience) and analyzed using BD FACS Diva software (BD Bioscience).
Analysis of cardiac function by echocardiography
Echocardiography was performed as described previously [25] .
Gravimetric analysis
Mice were weighted at day 7 after MI. The heart and lung were harvested after euthanasia by inhalation of isoflurane and washed with cold PBS. The weight of these organs was measured and normalized with body weight.
Enzyme-linked immunosorbent assay
Heart homogenates were prepared and IL-10 concentration in myocardium was evaluated with ELISA kit (BioLegend, ELISA MAX TM Deluxe Set#431414).
Statistical analysis
Data are shown as means ± SD. Survival rate was analyzed by the Kaplan-Meier method using a log-rank test. Comparisons between two groups were performed with the use of Student ttest. One-way ANOVA followed by a Tukey-Kramer or Dunnett test was used for multiple comparisons. P value < 0.05 was considered to be statistically significant.
Results
RORγt-expressing cells infiltrated in the heart after MI
We examined the expression of RORγt and IL-17A mRNA in post-infarct myocardium by quantitative RT-PCR ( Fig 1A) . After C57BL/6 mice were subjected to MI, mRNA expression was measured at various time points. The expression of RORγt and IL-17A transcripts was upregulated at day 1 and the expression of these genes displayed its peak at day 7 after MI. Consistently, immunohistochemical staining with anti-RORγt antibody revealed that RORγt-expressing cells infiltrated in the border area after MI, but not in remote area or sham operated hearts (Fig 1B and 1C) . Previously, we demonstrated that RORγt-expressing cells are required for the onset of experimental autoimmune myocarditis (EAM) [27] . Interestingly, it is reported that EAM is produced by adoptive transfer of splenocytes after MI [28] . Therefore, we examined RORγt-expressing cells infiltrated in the heart after MI. (A) C57BL/6 mice were subjected to MI operation, and hearts were harvested at the indicated time points. Total RNA was prepared from the ligation point to the apex of hearts, and quantitative RT-PCR was performed for RORγt (left) and IL-17A (right). The expression of RORγt and IL-17A mRNA was normalized with that of GAPDH and were shown as a ratio to the average value of non-MI. Data are shown as means ± SD; n = 7 for each condition. *P < 0.05 and **P < 0.01 vs non-MI by one-way ANOVA followed by Dunnett test. (B) The sections were prepared from the hearts at day 7 after MI, MI plus splenectomy or sham operation. Immunohistochemical analyses were performed with anti-RORγt antibody or mouse non-immune IgG as a control. Nuclei were stained by hematoxylin (Blue). Representative images at border zone and remote area are shown. The arrowhead indicates RORγt-positive cell (Brown). Bar = 50 μm. (C) Quantitative analyses of RORγt-expressing cells. Thirty visual fields at the border zone or remote area were photographed from 5 hearts. Cells that were positively stained with antiRORγt at nuclei were counted. Data are shown as means γ SD. n.d., not detectable, **P < 0.01 by one-way ANOVA followed by Turkey-Kramer test. the effects of the splenectomy on the infiltration of RORγt-expressing cells into post-infarct myocardium and found that the number of RORγt-expressing cells infiltration was reduced by splenectomy surgery (Fig 1B and 1C) . These data indicate that RORγt-expressing cells were released at least partially from the spleen. It should be noted that the infiltration of RORγt-expressing cells was not completely inhibited by splenectomy, suggesting that some fraction of RORγt-expressing cells were originated from other lymphoid tissues, such as lymph nodes.
RORγt-expressing cells were released from the spleen after MI
Since splenectomy reduced the number of RORγt-expressing cells that infiltrated post-infarct myocardium, we performed flow cytometric analysis for splenic leukocytes to characterize RORγt-expressing cells. Consistent with RORγt-expressing cells infiltration in infarcted heart, the number of leukocytes and RORγt-expressing cells in the spleen was reduced at day 1 after MI (Fig 2A) . (Fig 2C) . Considering that the expression of RORγt increased in the heart from day 1 to day 7 after MI, it is likely that majority of RORγt-expressing cells in post-infarct myocardium are RORγt + γδTCR + cells.
Heterozygous deletion of RORγt gene increased the mortality after MI
To analyze the pathophysiological significance of RORγt-expressing cells in post-infarct myocardium, we used RORγt +/-mice with eGFP gene heterozygously knocked-in at RORγt gene locus ( Fig 3A) . In order to confirm that RORγt gene was successfully reduced in RORγt +/-mice, we examined physiological expression of RORγt mRNA in the thymus by quantitative RT-PCR analysis, because RORγt mRNA is constitutively expressed in the thymus [9] . The RORγt mRNA expression was significantly suppressed in the thymus in RORγt +/-mice compared with WT mice (Fig 3B) . Similarly, the expression of RORγt in spleen has tendency to decrease in RORγt +/-mice with wide standard deviation, possibly because splenic cells are composed of more various immune cells than thymic cells. In comparison with the thymus, the expression of RORγt mRNA in non-MI hearts was very low in both RORγt +/-and WT mice. Consistently, echocardiographic analysis showed that there was no difference in cardiac function between these two groups of mice before MI (Table 1) . However, after MI, RORγt +/-mice showed higher rate of mortality (Fig 3C) , accompanied by aggravated cardiac dysfunction at day 7 after MI, compared with WT mice (Table 1) .
Adverse cardiac remodeling was exacerbated in RORγt +/-mice after MI
To make clear the effects of RORγt knockdown on adverse cardiac remodeling after MI, we conducted gravimetric analysis and measured severity of cardiac injury in RORγt +/-and WT mice (Fig 4) . In this study, we analyzed cardiac remodeling at day 7 after MI, because approximately 80% of RORγt +/-mice died by day 14 (Fig 3C) . Consistent with the aggravated cardiac dysfunction in RORγt +/-mice at day 7 after MI, the ratio of heart weight to body weight and lung weight to body weight were both increased in RORγt +/-mice after MI, compared with WT mice (Fig 4A) . Histological analyses by Masson's trichrome staining revealed that severity of cardiac injury, including cardiac fibrosis, was exacerbated in RORγt +/-mice after MI, although there was no histological difference between RORγt +/-mice and WT mice in shamoperated groups (Fig 4B) . We quantified injured area and circumference, and found that cardiac injury was significantly increased in RORγt +/-mice (Fig 4B and 4C ).
Capillary density was reduced in RORγt +/-hearts after MI
Impaired vascular formation in post-infarct myocardium aggravates adverse cardiac remodeling [29, 30] . Therefore, we measured capillary density at day 7 after MI by immunohistochemical staining with anti-CD31 antibody (Fig 5) . In the border zone, capillary density was significantly reduced in RORγt +/-mice relative to WT mice, whereas there was no difference between WT and RORγt +/-mice in sham-operation. To explore the mechanisms of impaired angiogenesis in RORγt +/-mice, the mRNA expression of angiogenetic factors, such as VEGF, CXCL5 and angiopoietin 2, was measured by quantitative PCR. While VEGF and CXCL5 mRNA expressions were unchanged between RORγt +/-mice and WT mice, angiopoietin 2 expression was significantly reduced in RORγt +/-mice at day 4 after MI ( Fig 5C) .
Effects of heterozygous RORγt deletion on cytokine production in postinfarct myocardium
The inflammatory reaction is closely associated with the progression of cardiac remodeling. Therefore, to assess the effects of heterozygous RORγt deletion on cytokine production, we performed quantitative RT-PCR and estimated mRNA expression of cytokines and their related genes (Fig 6) . The myocardial expression of RORγt, IL-17A, IL-17F, and IL-23R mRNA was significantly suppressed in RORγt +/-mice at day 7 after MI, compared with WT mice, respectively. Consistent with previous reports that IL-17 was thought to be only increased locally in the infarcted region after MI [31, 32] , there was no significant difference in serum IL-17 level between RORγt +/-and WT mice after MI (S1 Fig). Moreover, the expression of pro-inflammatory cytokines, including IL-6, IL-1β, TNF-α, and IFN-γ, as well as antiinflammatory cytokines, including IL-10 and TGF-β, was not influenced by heterozygous deletion of RORγt gene. Whereas, ELISA revealed that IL-10 protein in myocardium was reduced in RORγt +/-mice in comparison to control mice at day7 after MI.
Discussion
In post-infarct myocardium, immune cells positively or negatively modulate cardiac remodeling [1] [2] [3] [4] [5] [6] [7] [8] . Here, we have demonstrated that RORγt-expressing cells infiltrated into myocardium after MI. To analyze the pathophysiological roles of RORγt-expressing cells, MI was generated in RORγt +/-mice with eGFP gene heterozygously knocked-in at RORγt locus. In RORγt +/-mice, the mortality was increased with reduced expression of RORγt and IL-17A transcripts in post-infarct myocardium. Importantly, adverse cardiac remodeling was exacerbated in RORγt +/-mice, accompanied by reduced capillary density. These data suggest that RORγt-expressing cells play cardioprotective roles in cardiac remodeling after MI. In this study, we used RORγt +/-mice instead of RORγt-deficient mice, because RORγt -/-mice showed higher mortality immediately after MI. RORγt +/-mice grew normally and echocardiography showed that there was no difference in cardiac function between RORγt +/-and WT mice under physiological conditions. We confirmed that the expression level of RORγt transcript in the thymus was reduced by 41% in RORγt +/-mice, compared with WT, indicating that RORγt +/-mice could be used as RORγt knock-down model.
RORγt was originally identified as a transcription factor responsible for differentiation of IL-17-producing T cells [9, 10] . Previously, we have demonstrated that RORγt is essential for the induction of experimental autoimmune myocarditis (EAM) [27] ; however, the pathophysiological roles of RORγt-expressing cells poorly understand in cardiac remodeling after MI. RORγt is a transcriptional factor for various cytokines and their receptors, including IL-17A, IL-17F and IL-23R [22, 23] . Indeed, the expression of these cytokines and cytokine receptors was reduced in post-infarct myocardium in RORγt +/-mice. Interestingly, we showed that heterozygous deletion of RORγt gene exacerbated adverse cardiac remodeling after MI, suggesting that RORγt-expressing cells could prevent cardiac remodeling. Though RORγt is essential for Th17 differentiation, RORγt expression is not limited to Th17 cells [22, 23] . Our data presented here propose that RORγt-mediated regulation of inflammatory reaction could be crucial for protection from adverse cardiac remodeling, RORγt +/-mice and WT mice were subjected to MI operation, and hearts were harvested at day 7 after MI. Total RNA was prepared from hearts from the ligation point to the apex, and quantitative RT-PCR was performed for RORγt, IL-17A, IL-17F, IL-23R IL-6, IL-1β, TNF-α, IFN-γ, IL-10 and TGF-β mRNA levels. The expressions of the transcripts were normalized with that of GAPDH and shown as the ratio to the average value of WT mice. Data are shown as means ± SD; n = 13 for WT mice, 8 for RORγt +/-mice. *P < 0.05 and **P < 0.01 vs WT mice by Student's t-test. (B) Heart homogenate was prepared from infarct hearts of RORγt +/-mice and WT mice at day 7 after MI. ELISA was performed to evaluate the concentration of IL-10 protein. Data are shown as means ± SD; n = 6 for WT mice, n = 7 for RORγt+/-mice. **P < 0.01 vs WT mice by Student's t-test.
https://doi.org/10.1371/journal.pone.0183584.g006
Protective roles of RORγt-expressing cells subpopulation of γδTCR + cells could exert detrimental effects on cardiac remodeling after MI, though further studies would be needed to identify the subpopulation. It is interesting that capillary density was reduced in myocardium of RORγt +/-mice after MI. Since angiogenesis prevents post-infarct cardiac fibrosis [29, 30] , it is proposed that RORγt-expressing cells ameliorated cardiac remodeling at least partially by promoting angiogenesis. This proposal is supported by the finding that the expression of IL-17A and angiopoietin 2 was reduced in post-infarct myocardium in RORγt +/-mice. It is well known that IL-17A promotes vascular formation [36, 37] . Moreover, angiopoietin 2 positively regulates angiogenesis in autoimmune diseases [38] . Of course, we cannot exclude the possibility that other secretory factors or cytokines, produced from RORγt-expressing cells, were involved in cardioprotection, because it was reported that deficiency of IL-17A prevented cardiac remodeling and that IL-17A does not necessarily show the beneficial effects on cardiac remodeling [20, 21] .
In the present study, we have demonstrated that heterozygous ablation of RORγt gene exacerbated cardiac remodeling after MI. RORγt-expressing γδT cells exhibited preventive effects against cardiac remodeling at least partially through enhanced revascularization, proposing the cardioprotective property as a novel function of RORγt-expressing γδT cells. Modulation of RORγt + cell-mediated regulation of cardiac remodeling could be a promising therapeutic strategy for cardiovascular diseases. Limitations: It should be noted that male mice were exclusively used in this study as a limitation. In our previous study [27] , we examined the pathophysiological roles of RORγt in experimental autoimmune myocarditis (EAM) and found that RORγt is essential for the onset of EAM. In EAM experiments, we exclusively used male Balb/c mice because EAM can be induced more severely in male mice than in female, as reported previously [39] . Therefore, considering the possibility that the biological function of RORγt is dependent on sex difference and can be more remarkably observed in male mice, we designed this study as an exclusive study of male mice to make clear the biological roles of RORγt in cardiac remodeling after MI. 
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